Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve.
暂无分享,去创建一个
R. Levine | A. Carpentier | M. Handschumacher | J. Guerrero | A. Hagège | E. Messas | S. Sullivan | E. Aikawa | J. Hjortnaes | J. Beaudoin | J. Bischoff | P. Bartko | W. Irvin | Jill Wylie-Sears | C. Szymanski | Margo M. Seybolt | Michael L Garcia | J. Titus | Adam Mauskapf | Miguel Chaput | J. Dal-Bianco | J. L. Guerrero | Robert A. Levine | Albert Hagège | Michael L. Garcia | Philipp E. Bartko | James S. Titus | Whitney S. Irvin
[1] R. Levine,et al. Assessment of Mitral Valve Adaptation With Gated Cardiac Computed Tomography: Validation With Three-Dimensional Echocardiography and Mechanistic Insight to Functional Mitral Regurgitation , 2013, Circulation. Cardiovascular imaging.
[2] E. Schwammenthal,et al. Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle. , 2013, Journal of the American College of Cardiology.
[3] Ellen Kuhl,et al. Evidence of adaptive mitral leaflet growth. , 2012, Journal of the mechanical behavior of biomedical materials.
[4] Hiroyuki Okura,et al. Influence of chronic tethering of the mitral valve on mitral leaflet size and coaptation in functional mitral regurgitation. , 2012, JACC. Cardiovascular imaging.
[5] R. Bucala,et al. Fibrocytes in health and disease. , 2010, Experimental hematology.
[6] A. Leask. Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.
[7] R. Strieter,et al. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. , 2010, The international journal of biochemistry & cell biology.
[8] R. Levine,et al. Developmental basis of adult cardiovascular diseases , 2010, Annals of the New York Academy of Sciences.
[9] David Julius,et al. Cellular and Molecular Mechanisms of Pain , 2009, Cell.
[10] Suzanne Sullivan,et al. Mitral Leaflet Adaptation to Ventricular Remodeling: Prospective Changes in a Model of Ischemic Mitral Regurgitation , 2009, Circulation.
[11] K. Yutzey,et al. Heart Valve Development: Regulatory Networks in Development and Disease , 2009, Circulation research.
[12] Suzanne Sullivan,et al. Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation , 2009, Circulation.
[13] T. Denney,et al. Profibrotic Growth Factor Genes in Chronic Isolated Mitral Regurgitation in the Dog Microarray Identifies Extensive Downregulation of Noncollagen Extracellular Matrix and , 2009 .
[14] A. Gotlieb,et al. Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells. , 2008, The American journal of pathology.
[15] K. J. Grande-Allen,et al. The Effects of Mitral Regurgitation Alone Are Sufficient for Leaflet Remodeling , 2008, Circulation.
[16] Robert A Levine,et al. Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation , 2008, Circulation.
[17] M. Burdick,et al. Differentiation of Human Circulating Fibrocytes as Mediated by Transforming Growth Factor-β and Peroxisome Proliferator-activated Receptor γ* , 2007, Journal of Biological Chemistry.
[18] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[19] N. Frangogiannis,et al. The role of TGF-β Signaling in Myocardial Infarction and Cardiac Remodeling , 2007 .
[20] R. Gomer,et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice , 2006, Proceedings of the National Academy of Sciences.
[21] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[22] Magdi H. Yacoub,et al. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. , 2006, Cardiovascular research.
[23] R. Markwald,et al. An In Vivo Analysis of Hematopoietic Stem Cell Potential: Hematopoietic Origin of Cardiac Valve Interstitial Cells , 2006, Circulation research.
[24] F. Schoen,et al. Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering , 2006, Circulation.
[25] P. McCarthy,et al. Mitral valve stiffening in end-stage heart failure: evidence of an organic contribution to functional mitral regurgitation. , 2005, The Journal of thoracic and cardiovascular surgery.
[26] Arjun Deb,et al. Bone marrow-derived myofibroblasts are present in adult human heart valves. , 2005, The Journal of heart valve disease.
[27] Y. Suematsu,et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. , 2005, Journal of the American College of Cardiology.
[28] B. Griffin,et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. , 2005, Journal of the American College of Cardiology.
[29] D. Judge,et al. TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .
[30] Gideon Cohen,et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. , 2004, The Journal of thoracic and cardiovascular surgery.
[31] R. Levine,et al. Mechanism of Recurrent Ischemic Mitral Regurgitation After Annuloplasty: Continued LV Remodeling as a Moving Target , 2004, Circulation.
[32] Joyce Bischoff,et al. Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.
[33] S. Rosenkranz. TGF-β1 and angiotensin networking in cardiac remodeling , 2004 .
[34] L. Leinwand,et al. Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease , 2004, Circulation research.
[35] N. Khaper,et al. Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.
[36] Douglas L Mann,et al. Stress-activated cytokines and the heart: from adaptation to maladaptation. , 2003, Annual review of physiology.
[37] S. Bolling,et al. Myocardial Proinflammatory Cytokine Expression and Left Ventricular Remodeling in Patients With Chronic Mitral Regurgitation , 2003, Circulation.
[38] P. Libby,et al. Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.
[39] K. Bailey,et al. Ischemic Mitral Regurgitation: Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment , 2001, Circulation.
[40] A. Matsumori,et al. Roles and Relationship of Macrophages and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Ischemic and Reperfused Rat Heart , 2000, Laboratory Investigation.
[41] A. Carpentier,et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. , 1999, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[42] K S Kunzelman,et al. Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis. , 1998, The Annals of thoracic surgery.
[43] J. Gorman,et al. Infarct size and location determine development of mitral regurgitation in the sheep model. , 1998, The Journal of thoracic and cardiovascular surgery.
[44] R A Levine,et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. , 1997, Circulation.
[45] Richard P. Cochran,et al. Collagen Synthesis Is Upregulated in Mitral Valves Subjected to Altered Stress , 1996, ASAIO journal.
[46] S. Goldstein,et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. , 1992, Journal of the American College of Cardiology.
[47] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[48] Timothy J Gardner,et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. , 2014, The New England journal of medicine.
[49] M. Burdick,et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. , 2007, The Journal of biological chemistry.
[50] N. Frangogiannis,et al. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. , 2007, Cardiovascular research.
[51] Raymond B. Runyan,et al. Cell biology of cardiac cushion development. , 2005, International review of cytology.
[52] S. Rosenkranz. TGF-beta1 and angiotensin networking in cardiac remodeling. , 2004, Cardiovascular research.
[53] D. Judge,et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.
[54] M. Entman,et al. The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.